amifampridine has been researched along with Diplopia in 1 studies
Amifampridine: 4-Aminopyridine derivative that acts as a POTASSIUM CHANNEL blocker to increase release of ACETYLCHOLINE from nerve terminals. It is used in the treatment of CONGENITAL MYASTHENIC SYNDROMES.
Diplopia: A visual symptom in which a single object is perceived by the visual cortex as two objects rather than one. Disorders associated with this condition include REFRACTIVE ERRORS; STRABISMUS; OCULOMOTOR NERVE DISEASES; TROCHLEAR NERVE DISEASES; ABDUCENS NERVE DISEASES; and diseases of the BRAIN STEM and OCCIPITAL LOBE.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Helmchen, C | 1 |
| Sprenger, A | 1 |
| Rambold, H | 1 |
| Sander, T | 1 |
| Kömpf, D | 1 |
| Straumann, D | 1 |
1 other study available for amifampridine and Diplopia
| Article | Year |
|---|---|
Effect of 3,4-diaminopyridine on the gravity dependence of ocular drift in downbeat nystagmus.
Topics: 4-Aminopyridine; Amifampridine; Cerebellum; Diplopia; Electronystagmography; Female; Gravitation; He | 2004 |